An Animal Model of Oxaliplatin-induced Cold Allodynia Reveals a Crucial Role for Nav1.6 in Peripheral Pain Pathways
Overview
Authors
Affiliations
Cold allodynia, pain in response to cooling, occurs during or within hours of oxaliplatin infusion and is thought to arise from a direct effect of oxaliplatin on peripheral sensory neurons. To characterize the pathophysiological mechanisms underlying acute oxaliplatin-induced cold allodynia, we established a new intraplantar oxaliplatin mouse model that rapidly developed long-lasting cold allodynia mediated entirely through tetrodotoxin-sensitive Nav pathways. Using selective inhibitors and knockout animals, we found that Nav1.6 was the key isoform involved, while thermosensitive transient receptor potential channels were not involved. Consistent with a crucial role for delayed-rectifier potassium channels in excitability in response to cold, intraplantar administration of the K(+)-channel blocker 4-aminopyridine mimicked oxaliplatin-induced cold allodynia and was also inhibited by Nav1.6 blockers. Intraplantar injection of the Nav1.6 activator Cn2 elicited spontaneous pain, mechanical allodynia, and enhanced 4-aminopyridine-induced cold allodynia. These findings provide behavioural evidence for a crucial role of Nav1.6 in multiple peripheral pain pathways including cold allodynia.
Voltage-gated sodium channels in excitable cells as drug targets.
Alsaloum M, Dib-Hajj S, Page D, Ruben P, Krainer A, Waxman S Nat Rev Drug Discov. 2025; .
PMID: 39901031 DOI: 10.1038/s41573-024-01108-x.
TET1 participates in oxaliplatin-induced neuropathic pain by regulating microRNA-30b/Nav1.6.
Zhao S, Zhang J, Zhang M, Yang Q, Li Z, Ren X J Biol Chem. 2025; 301(3):108228.
PMID: 39864621 PMC: 11894311. DOI: 10.1016/j.jbc.2025.108228.
Differential encoding of mammalian proprioception by voltage-gated sodium channels.
Espino C, Nagaraja C, Ortiz S, Dayton J, Murali A, Ma Y Sci Adv. 2025; 11(2):eads6660.
PMID: 39772670 PMC: 11708877. DOI: 10.1126/sciadv.ads6660.
Guo W, Yang H, Wang Y, Liu T, Pan Y, Chen X Neuropsychopharmacology. 2024; 50(4):662-672.
PMID: 39414988 PMC: 11845512. DOI: 10.1038/s41386-024-01998-w.
Luo S, Zhou X, Wu M, Wang G, Wang L, Feng X Adv Sci (Weinh). 2024; 11(42):e2406656.
PMID: 39248322 PMC: 11558128. DOI: 10.1002/advs.202406656.